Ascentage Pharma Group Stock Alpha and Beta Analysis
| AAPG Stock | 27.88 1.39 5.25% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ascentage Pharma Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ascentage Pharma over a specified time horizon. Remember, high Ascentage Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ascentage Pharma's market risk premium analysis include:
Beta 0.83 | Alpha (0.58) | Risk 3.49 | Sharpe Ratio (0.12) | Expected Return (0.42) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ascentage | Build AI portfolio with Ascentage Stock |
Ascentage Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ascentage Pharma market risk premium is the additional return an investor will receive from holding Ascentage Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ascentage Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ascentage Pharma's performance over market.| α | -0.58 | β | 0.83 |
Ascentage Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Ascentage Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Ascentage Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Ascentage Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Ascentage Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascentage Pharma shares will generate the highest return on investment. By understating and applying Ascentage Pharma stock market price indicators, traders can identify Ascentage Pharma position entry and exit signals to maximize returns.
Ascentage Pharma Return and Market Media
The median price of Ascentage Pharma for the period between Thu, Sep 25, 2025 and Wed, Dec 24, 2025 is 33.4 with a coefficient of variation of 9.91. The daily time series for the period is distributed with a sample standard deviation of 3.35, arithmetic mean of 33.84, and mean deviation of 2.73. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Why analysts maintain buy rating on Ascentage Pharma Group International stock - Weekly Stock Recap Weekly Return Optimization Alerts - newser.com | 11/18/2025 |
2 | Assessing Ascentage Pharma Valuation Following Major Data Publication on Olverembatinib in Rare GIST Subtype - simplywall.st | 11/26/2025 |
3 | Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025 | 12/01/2025 |
4 | Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph ALL Cleared by US FDA and EMA | 12/05/2025 |
5 | ASH 2025 Ascentage Pharma Presents Encouraging Data from Phase IbII Study of Bcl-2 Inhibitor Lisaftoclax in VenetoclaxExposed Patients with Myeloid Malignances | 12/08/2025 |
6 | ASH 2025 Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph ALL Shows a Best MRD-Negativity CR Rate ... | 12/09/2025 |
7 | Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference | 12/17/2025 |
8 | Ascentage Pharma Group International Stock Price Down 5.5 percent - Should You Sell - MarketBeat | 12/22/2025 |
About Ascentage Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ascentage or other stocks. Alpha measures the amount that position in Ascentage Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.23 | 0.42 | 0.32 | 0.46 | Days Of Inventory On Hand | 156.77 | 193.2 | 82.79 | 78.65 |
Ascentage Pharma Investors Sentiment
The influence of Ascentage Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ascentage. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ascentage Pharma's public news can be used to forecast risks associated with an investment in Ascentage. The trend in average sentiment can be used to explain how an investor holding Ascentage can time the market purely based on public headlines and social activities around Ascentage Pharma Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ascentage Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ascentage Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ascentage Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ascentage Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ascentage Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ascentage Pharma's short interest history, or implied volatility extrapolated from Ascentage Pharma options trading.
Build Portfolio with Ascentage Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Ascentage Pharma Backtesting, Ascentage Pharma Valuation, Ascentage Pharma Correlation, Ascentage Pharma Hype Analysis, Ascentage Pharma Volatility, Ascentage Pharma History and analyze Ascentage Pharma Performance. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Ascentage Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.